PURPOSE: The correlation of advanced cancer with inflammation and/or nutrition factors is well known. Recently, the advanced lung cancer inflammation index (ALI) was developed as a new prognostic tool for patients with advanced lung cancer. In this study, we examined whether ALI results are correlated with prognosis of patients with early stage lung adenocarcinoma who undergo lung resection. METHODS: From January 2009 to December 2014, 544 patients underwent lung resection due to primary lung cancer at Dokkyo Medical University Hospital, of whom 166 with pathological stage IA lung adenocarcinoma were retrospectively investigated in this study. ALI was calculated as follows: Body Mass Index (BMI; kg/m2) × albumin (g/dL)/neutrophil-to-lymphocyte ratio (NLR). RESULTS: Multivariate analysis revealed that gender, red cell distribution width (RDW), NLR, and ALI were parameters significantly correlated with overall survival (OS). Patients with an ALI value less than 22.2 had an inferior 5-year OS rate as compared to those with a value of 22.2 or higher (p <0.001) as well as an inferior 5-year recurrence-free survival (RFS) rate (p <0.001). CONCLUSION: Low ALI was correlated with poor prognosis in patients with stage IA lung adenocarcinoma. Those with an ALI value less than 22.2 should be carefully followed regardless of cancer stage.
PURPOSE: The correlation of advanced cancer with inflammation and/or nutrition factors is well known. Recently, the advanced lung cancer inflammation index (ALI) was developed as a new prognostic tool for patients with advanced lung cancer. In this study, we examined whether ALI results are correlated with prognosis of patients with early stage lung adenocarcinoma who undergo lung resection. METHODS: From January 2009 to December 2014, 544 patients underwent lung resection due to primary lung cancer at Dokkyo Medical University Hospital, of whom 166 with pathological stage IA lung adenocarcinoma were retrospectively investigated in this study. ALI was calculated as follows: Body Mass Index (BMI; kg/m2) × albumin (g/dL)/neutrophil-to-lymphocyte ratio (NLR). RESULTS: Multivariate analysis revealed that gender, red cell distribution width (RDW), NLR, and ALI were parameters significantly correlated with overall survival (OS). Patients with an ALI value less than 22.2 had an inferior 5-year OS rate as compared to those with a value of 22.2 or higher (p <0.001) as well as an inferior 5-year recurrence-free survival (RFS) rate (p <0.001). CONCLUSION: Low ALI was correlated with poor prognosis in patients with stage IA lung adenocarcinoma. Those with an ALI value less than 22.2 should be carefully followed regardless of cancer stage.
Authors: Michael J Proctor; David S Morrison; Dinesh Talwar; Steven M Balmer; Colin D Fletcher; Denis St J O'Reilly; Alan K Foulis; Paul G Horgan; Donald C McMillan Journal: Eur J Cancer Date: 2011-07-01 Impact factor: 9.162
Authors: Khaled M Sarraf; Elizabeth Belcher; Evgeny Raevsky; Andrew G Nicholson; Peter Goldstraw; Eric Lim Journal: J Thorac Cardiovasc Surg Date: 2008-08-29 Impact factor: 5.209
Authors: Nilanjana Tewari; Antonio E Martin-Ucar; Edward Black; Lynda Beggs; F David Beggs; John P Duffy; W Ellis Morgan Journal: Lung Cancer Date: 2007-05-03 Impact factor: 5.705
Authors: Dominik Andreas Barth; Carina Brenner; Jakob Michael Riedl; Felix Prinz; Eva Valentina Klocker; Konstantin Schlick; Peter Kornprat; Karoline Lackner; Herbert Stöger; Michael Stotz; Armin Gerger; Martin Pichler Journal: Cancer Med Date: 2020-06-14 Impact factor: 4.711